Important Safety Information    Please click here for full Prescribing Information PHN Therapy Can Star Here

Journal Articles


Read pertinent clinical research from leading publications in the treatment of PHN pain management.

Andreas Binder, Jean Bruxelle, Peter Rogers, Guy Hans, Irmgard Bo¨sl, and Ralf Baron. Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia: Results of a Double-Blind, Placebo-Controlled, Multinational Efficacy and Safety Trial. Clinical Drug Investigations. 2009; 29 (6): Pg. 393-408.

R.M. Dubinsky, MD, MPH; H. Kabbani, MD; Z. El-Chami, MD; C. Boutwell, MD; and H. Ali, MD. Practice Parameter: Treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards. Subcommittee of the American Academy of Neurology*. Neurology. 2004; 63 (9): Pg. 946-965.

Bradley S. Galer, Michael C. Rowbotham, Jill Perander, and Erika Friedman. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;
80: Pg. 533-538.

Michael C. Rowbatham, Pamela S. Davies, Christian Verkempinck, and Bradley S. Galer. Lidocaine patch: Double-blind study of a new treatment for post-herpetic neuralgia. Pain. 1996: Pg. 39-44.

Intended for US Residents Only
LIDODERM® Home | LIDODERM® HCP Home | About After-Shingles Pain (PHN) | Pain Assessment Tool & Checklist
About the LIDODERM® Patch | Resources | Important Safety Information | Prescribing Information
Signup for Email Updates | Privacy/Legal | Site Map | Contact Us


© 2011 Endo Pharmaceuticals. All rights reserved.
LIDODERM® is a registered trademark of Hind Health Care, Inc.
LD-01580/September 2011
rx_only